GLI3 and cancer: The odd ratio for cancer relapse in high GLI1/GLI3 expression is 1.69, indicating that high expression of GLI1/GLI3 signaling molecules increases the risk of cancer relapse by 69% in colorectal cancer patients after chemotherapy.